470702-34-2 Usage
Uses
Used in Pharmaceutical Industry:
7-Methoxy-2-methylquinoline-3-carboxylic acid is used as a pharmaceutical compound for its potential antibacterial and antifungal properties. It is being studied for its ability to treat various infections caused by bacteria and fungi.
Used in Drug Development:
7-Methoxy-2-methylquinoline-3-carboxylic acid is used as a starting material in the development of new drugs for the treatment of infections. Its unique structure and functional groups make it a promising candidate for the design and synthesis of novel therapeutic agents.
Used in Organic Synthesis:
7-Methoxy-2-methylquinoline-3-carboxylic acid is used as a building block in the research and development of organic synthesis. Its carboxylic acid functional group allows for various chemical reactions, making it a versatile compound for the synthesis of complex organic molecules.
Used in Medicinal Chemistry:
7-Methoxy-2-methylquinoline-3-carboxylic acid is used as a research tool in medicinal chemistry. Its potential pharmaceutical properties and unique structure make it a valuable compound for studying the mechanisms of action and developing new therapeutic agents for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 470702-34-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,0,7,0 and 2 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 470702-34:
(8*4)+(7*7)+(6*0)+(5*7)+(4*0)+(3*2)+(2*3)+(1*4)=132
132 % 10 = 2
So 470702-34-2 is a valid CAS Registry Number.
InChI:InChI=1/C12H11NO3/c1-7-10(12(14)15)5-8-3-4-9(16-2)6-11(8)13-7/h3-6H,1-2H3,(H,14,15)
470702-34-2Relevant academic research and scientific papers
Quinoline inhibitors of hyaki and hyak3 kinases
-
Page/Page column 16, (2008/06/13)
This invention relates to novel quinoline inhibitors of hYAK1 and hYAK3 kinases and pharmaceutically acceptable salts, hydrates or solvates thereof, pharmaceutical compositions thereof, and methods of treatment of diseases in which an excessive amount of
